Thanks for the encouragement, everyone. I am a geno 1 and have been through tx with IFN/riba w/out a SVR. So maybe it wont be too much of a battle.
Another way insurance might handle this is to require other methods to be tried first; i.e. if a patient fails IFN/riba they’d then qualify for the addition of protease inhibitors. I’m not saying this with any personal knowledge of the situation, only speculating. I think this has precedent though.
Bill
On the other hand, the new stuff will not be cheap. Plus, they will need to make separate decisions for non-geno 1's likely.
Maybe I'm too much of an optimist but I truly believe that the insurance companies will get on board with the new meds. It's as much in their best interest as ours to have us use the new meds because of the higher success rate and less chance of having to do treatment over.
My GI doc basically said: the new drugs will become SOC and therefore will be covered but we don't know how much pain and suffering the insurance company will put you through initially.
We shall see.